AIM ImmunoTech (AIM) Payables (2010 - 2026)
AIM ImmunoTech's (AIM) quarterly Payables came in at $5.2 million in Q1 2026, down 41.32% YoY from $8.9 million in Q1 2025, and up 0.77% on a QoQ basis from $5.2 million in Q4 2025.
AIM ImmunoTech (AIM) Payables (2010 - 2026) Analysis & Trends
AIM ImmunoTech (AIM) has 17 years of Payables data on file, last reported at $5.2 million in Q1 2026.
- Quarterly Payables fell 41.32% year-over-year to $5.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.2 million (down 41.32% YoY) and the FY2025 annual result came in at $5.2 million, down 40.4% from the prior year.
- Payables rose to $5.2 million in Q1 2026, from $5.2 million in the prior quarter.
- In the past five years, Payables ranged from a high of $9.6 million in Q2 2025 to a low of $377000.0 in Q4 2022.
- A 5-year average of $4.7 million and a median of $5.2 million in 2025 frame the typical range for Payables.
- Annual changes were most pronounced in 2023 — Payables jumped 1609.02% — and 2025, when it sank 64.64%.
- Tracing AIM's Payables over 5 years: stood at $377000.0 in 2022, then jumped by 1609.02% to $6.4 million in 2023, then soared by 34.88% to $8.7 million in 2024, then plunged by 40.4% to $5.2 million in 2025, then rose by 0.77% to $5.2 million in 2026.
- The last three Payables figures came in at $5.2 million (Q1 2026), $5.2 million (Q4 2025), and $3.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.61 Bn | 131.75 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 65.28 Bn | 60.09 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 59.14 Bn | 54.00 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 42.13 Bn | 37.03 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.83 Bn | 28.52 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.07 Bn | 9.68 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 35.57 Mn |
| 10 | AIM ImmunoTech | 4.46 Mn | -5.51 Mn | 21,000.00 | 4.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.10 Mn |
| Mar 31, 2026 | 5.22 Mn |
| Dec 31, 2025 | 5.18 Mn |
| Sep 30, 2025 | 3.13 Mn |
| Jun 30, 2025 | 9.59 Mn |
| Mar 31, 2025 | 8.89 Mn |
| Dec 31, 2024 | 8.69 Mn |
| Sep 30, 2024 | 8.86 Mn |
| Jun 30, 2024 | 7.81 Mn |
| Mar 31, 2024 | 8.19 Mn |
| Dec 31, 2023 | 6.44 Mn |
| Sep 30, 2023 | 2.79 Mn |
| Jun 30, 2023 | 2.15 Mn |
| Mar 31, 2023 | 963,000.00 |
| Dec 31, 2022 | 377,000.00 |
| Sep 30, 2022 | 957,000.00 |
| Jun 30, 2022 | 712,000.00 |
| Mar 31, 2022 | 378,000.00 |
| Dec 31, 2021 | 198,000.00 |
| Sep 30, 2021 | 369,000.00 |